Anika to Participate in Upcoming Virtual Investor Conferences

Rhea-AI Summary

Anika Therapeutics (NASDAQ: ANIK) announced participation in three upcoming virtual investor conferences this May. Dr. Cheryl Blanchard, CEO, and Michael Levitz, CFO, will present at the following events: the 16th Annual Canaccord Genuity Musculoskeletal Conference on May 20, starting at 9:00 a.m. ET, the UBS Global Healthcare Virtual Conference on May 25, starting at 8:00 a.m. ET, and Oppenheimer’s MedTech Summit with a pre-recorded session on May 26. All presentations will be accessible via Anika's Investor Relations website.

BEDFORD, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will be participating at the following three virtual investor conferences in May:

• The 16th Annual Canaccord Genuity Musculoskeletal Conference on Thursday, May 20, 2021 will host a live presentation starting at 9:00 a.m. ET.
• The UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 will host a live presentation starting at 8:00 a.m. ET.
• Oppenheimer’s MedTech, Tools & Diagnostics Summit will post a pre-recorded presentation on Wednesday, May 26, 2021.
  

Webcasts of all events will be available in the Investor Relations section of Anika’s website, www.anika.com. An audio archive of the all the presentations will also be available on the website.

About Anika

Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with clinicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. Anika is headquartered in Massachusetts with operations in the United States and Europe. For more information about Anika, please visit www.anika.com.

For Investor Inquiries:
Mark Namaroff
Anika Therapeutics, Inc.
Executive Director, Investor Relations and Corporate Communications
Direct: 781-457-9287
mnamaroff@anika.com

FAQ

What events is Anika (NASDAQ: ANIK) participating in during May 2021?

Anika Therapeutics is participating in the Canaccord Genuity Musculoskeletal Conference on May 20, the UBS Global Healthcare Virtual Conference on May 25, and Oppenheimer's MedTech Summit on May 26, 2021.

When can I watch Anika's presentations from the conferences?

Webcasts of all presentations will be available on Anika's Investor Relations website following the events.

Who from Anika will present at the investor conferences?

Dr. Cheryl Blanchard, President and CEO, and Michael Levitz, Executive Vice President and CFO, will present at the conferences.

What time does Anika's presentation at the Canaccord Genuity Conference start?

Anika's presentation at the Canaccord Genuity Musculoskeletal Conference starts at 9:00 a.m. ET on May 20, 2021.

What is Anika's focus in the orthopedic sector?

Anika Therapeutics focuses on joint preservation and early intervention in orthopedic care, aiming to improve patient outcomes in osteoarthritis and related conditions.